First oral warfarin alternative approved in the US.
Hughes
Bethan
B
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D058833:Antithrombin Proteins / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000379:methods; D000069604:Dabigatran; D017277:Drug Approval / Q000379:methods; D055808:Drug Discovery / Q000639:trends*; D006801:Humans; D011355:Prodrugs / Q000008:administration & dosage* / Q000009:adverse effects; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects; D014481:United States; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
D000925:Anticoagulants; D058833:Antithrombin Proteins; D001562:Benzimidazoles; D011355:Prodrugs; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran